Dr. David J. Grelotti, MD

Dr. Grelotti practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Grelotti's NPI, 1619003035, was assigned on February 27, 2007. Dr. Grelotti graduated from The Johns Hopkins University School of Medicine in 2006. Dr. Grelotti's Massachusetts license number on file is 234955.

Dr. Grelotti's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Grelotti's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Grelotti is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grelotti practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Grelotti's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Grelotti is board certified in child & adolescent psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Grelotti's licenses on file in 2 states: Massachusetts and California.

Dmand AI lists ADHD, adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, drug use disorders and insomnia among the conditions Dr. Grelotti treats.

CMS data shows 419 Medicare services from Dr. Grelotti across 5 procedure codes in 2024, for 69 Medicare patients. Medicare paid $21,222 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 69 Medicare patients who saw Dr. Grelotti in 2024. The largest group is under 65, with 39 patients. 75% of them have mood disorders, and 72% have high blood pressure. 80% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grelotti's median patient age at 47, with 15% women.

In 2024, Dr. Grelotti wrote 1,590 Medicare Part D claims for 102 patients. 85% of them were for generic drugs. CMS names the drug for 1,485 of them, across 36 drugs with 11 or more claims each, at $391,114 in total drug cost. In 2023, CMS named 1,532 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Grelotti for performance year 2024, reported as part of a group. Dr. Grelotti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grelotti as offering telehealth.

Dmand AI links 9 papers to Dr. Grelotti, published from 2014 to 2017. The most frequent topics are HIV Infections, Qualitative Research and South Africa. Dr. Grelotti's most frequent co-authors are Katerina A. Christopoulos, MD, MPH, Igor Grant, MD and Ingrid T. Katz, MD.

CMS Open Payments shows 75 general payments to Dr. Grelotti from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. GW Pharmaceuticals plc paid the most, $5,102.

Dr. Grelotti graduated from The Johns Hopkins University School of Medicine in 2006.

Dr. Grelotti is in network with 8 carriers, including Blue Cross Blue Shield of Michigan, Humana and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.